Skip to Content

Mycapssa Prices, Coupons and Patient Assistance Programs

Mycapssa (octreotide) is a member of the somatostatin and somatostatin analogs drug class and is commonly used for Acromegaly.

Mycapssa Prices

The cost for Mycapssa oral delayed release capsule 20 mg is around $2,946 for a supply of 28 capsules, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Mycapssa is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Mycapssa availability.

This Mycapssa price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Oral Delayed Release Capsule Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Mycapssa Coupons and Rebates

Mycapssa offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Mycapssa CAPS Program: Eligible commercially insured patients may pay as little as $0 per fill; for additional information contact the program at 833-346-2277.

Applies to:
Number of uses:
Per prescription until program expires

Form more information phone: 833-346-2277 or Visit website

Patient Assistance Programs for Mycapssa

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Mycapssa (octreotide) Capsule; Delayed Release

More information please phone: 866-316-7263 Visit Website

Provider: Chiasma Access & Patient Support (CAPS) Program

Elligibility requirements:
  1. Determined case by case
  2. Determined case by case
  3. FDA-approved diagnosis
  4. Must be a US resident and treated by a US licensed healthcare provider
  5. Patient Support and co-payment assistance available for eligible patients
Applicable drugs:
  • Mycapssa (octreotide) Capsule; Delayed Release

More information please phone: 833-346-2277 Visit Website